Varun Moktan
Gastroenterology · Charlotte, NCNPI 1871150482
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.9% of the total across 70 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 24 manufacturers reported payments, led by AbbVie at 34.8% of the total. Reporting peaked in 2024 at $2,234 and has fallen 78.5% since, to $480 in 2025.
Across 70 payments — averaging $51.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Johnson & Johnson$392
- 3-d Matrix, Inc.$388
- Takeda Pharmaceuticals U.S.A., Inc.$280
- Lilly USA, LLC$216
- Medtronic$174
- plus $898 from 18 others
What the payments were for
- Food & beverage$3,52998%
- Education$752%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 24 | $1,254 |
| Johnson & Johnson | 7 | $392 |
| 3-d Matrix, Inc. | 2 | $388 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $280 |
| Lilly USA, LLC | 3 | $216 |
| Medtronic | 2 | $174 |
| Olympus America Inc. | 1 | $120 |
| ERBE USA Inc | 1 | $111 |
| Madrigal Pharmaceuticals | 2 | $105 |
| Janssen Scientific Affairs, LLC | 1 | $97 |
| Enterra Medical, Inc. | 1 | $88 |
| Bristol Myers Squibb | 3 | $52 |
| Ardelyx, Inc. | 2 | $45 |
| Boston Scientific | 2 | $43 |
| Intercept Pharmaceuticals, Inc. | 2 | $36 |
| Sanofi | 1 | $34 |
| Cook Medical LLC | 1 | $29 |
| Regeneron Healthcare Solutions, Inc. | 1 | $28 |
| QOL Medical, LLC | 1 | $25 |
| Organon | 1 | $23 |
| Merck | 1 | $19 |
| Ferring Pharmaceuticals Inc. | 1 | $16 |
| Aimmune Therapeutics, Inc. | 1 | $14 |
| Endogastric Solutions, Inc | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,604 in reported general payments places this provider in the 60th percentile of 610 gastroenterology providers in North Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl | 12 | $143 |
Paid to pharmacies, not to this prescriber.
Other gastroenterology in Charlotte
- Stephen DealCharlotte$945K
- Fred FowlerCharlotte$932K
- Nilesh LodhiaCharlotte$735K
- Oscar BrannCharlotte$136K
- Philippe ZamorCharlotte$132K
- Kent HoltzmullerCharlotte$131K
- Baharak MoshireeCharlotte$105K
- Sagar PatelCharlotte$85K
- Olanrewaju JimohCharlotte$67K
- Sean RudnickCharlotte$60K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.